Filing Flows › Strata Critical Medical (SRTA) › Q2 2026 › vs Q1 2026
Strata Critical Medical (SRTA) Q2 2026 vs Q1 2026 (quarter over quarter)
Strata Critical Medical's revenue rose $5.1M (+8%) from $67.4M in Q1 2026 to $72.5M in Q2 2026.
Strata Critical Medical, Q2 2026: revenue $72.5M (+61% year over year), operating margin -7.5%, net loss $10.5M, operating cash flow $5.7M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $72.5M | $67.4M | $5.1M | +8% |
| Net loss | $10.5M | −$2.2M | $12.7M | — |
| Costs & expenses | $83.0M | $72.5M | $10.5M | +14% |
| Operating costs | $77.9M | $70.4M | $7.6M | +11% |
| Interest & other, net | $5.1M | −$5.1M | $10.2M | — |
| Cost of revenue | $57.3M | $53.3M | $4.0M | +8% |
| SG&A | $14.0M | $15.6M | −$1.6M | -10% |
| Other operating costs | $6.6M | $1.5M | $5.1M | +346% |
| Operating cash sources | $16.2M | $1.7M | $14.5M | +836% |
| Depreciation & amortization | $8.5M | $3.1M | $5.5M | +178% |
| Share-based compensation | $3.7M | $5.0M | −$1.3M | -26% |
| Working capital & other | $4.0M | −$6.4M | $10.3M | — |
| Net loss absorbed | $10.5M | −$2.2M | $12.7M | — |
| Operating cash flow | $5.7M | $3.9M | $1.8M | +46% |
Questions
How much did Strata Critical Medical's revenue grow quarter over quarter in Q2 2026?
Strata Critical Medical's revenue rose $5.1M (+8%) from $67.4M in Q1 2026 to $72.5M in Q2 2026.